Drug Approvals

Piasky: A Novel Treatment for Paroxysmal Nocturnal Hemoglobinuria Approved on Jun 24, 2024

Piasky: A Novel Treatment for Paroxysmal Nocturnal Hemoglobinuria Approved on Jun 24, 2024

What is it prescribed for? Piasky is indicated for the treatment of adult and pediatric patients 13 years and older with paroxysmal nocturnal hemoglobinuria (PNH) and body weight of at least 40 kg. What is the name of the drug and what does it do? Piasky (pronounced PEE-ah-skee), (generic name: crovalimab-akkz), is a medication indicated for the treatment of...

Ohtuvayre: A New Maintenance Treatment for COPD Approved on June 26, 2024

Ohtuvayre: A New Maintenance Treatment for COPD Approved on June 26, 2024

What is it prescribed for? Ohtuvayre is indicated for the maintenance treatment of chronic obstructive pulmonary disease. What is the name of the drug and what does it do? Ohtuvayre (pronounced OH-too-vare), (generic name: ensifentrine), is a medication indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. It...

Leqselvi: A New Treatment for Severe Alopecia Areata Approved July 25, 2024

Leqselvi: A New Treatment for Severe Alopecia Areata Approved July 25, 2024

What is it prescribed for? Leqselvi is indicated for the treatment of adults with severe alopecia areata (patchy hair loss). What is the name of the drug and what does it do? Leqselvi (pronounced lek-sel-vee), (generic name: deuruxolitinib), is a medication used to treat adults with severe alopecia areata, a condition characterized by significant hair loss. How does...

Kisunla: A Promising New Treatment for Alzheimer’s Disease Approved on July 2, 2024

Kisunla: A Promising New Treatment for Alzheimer’s Disease Approved on July 2, 2024

What is it prescribed for? Kisunla is indicated for the treatment of Alzheimer’s disease. What is the name of the drug and what does it do? Kisunla (pronounced kih-SUHN-lah), (generic name: donanemab-azbt), is a medication indicated for the treatment of Alzheimer’s disease. It is specifically for people with mild cognitive impairment or mild dementia who have...

Zepbound Injection Approved for Weight Loss in Overweight and Obese Adults on November 8, 2023

Zepbound Injection Approved for Weight Loss in Overweight and Obese Adults on November 8, 2023

What is Zepbound prescribed for?   Zepbound is prescribed for Chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg/ m2) or greater) or overweight (body mass index of 27 kg/m2 or greater) with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in...

Brixadi Approved  for Treatment of Opioid Use Disorder on May 05, 2023

Brixadi Approved  for Treatment of Opioid Use Disorder on May 05, 2023

What is Brixadi prescribed for? Brixadi is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine.  What is the name of the drug and what does it do? Brixadi, pronounced brix-a-dee, (generic name:...